1. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009. 373:1550–1561.
2. Westeneng AC, Hettinga Y, Lokhorst H, et al. Ocular graft-versus-host disease after allogeneic stem cell transplantation. Cornea. 2010. 29:758–763.
3. Tabbara KF, Al-Ghamdi A, Al-Mohareb F, et al. Ocular findings after allogeneic hematopoietic stem cell transplantation. Ophthalmology. 2009. 116:1624–1629.
4. Franklin RM, Kenyon KR, Tutschka PJ, et al. Ocular manifestations of graft-vs-host disease. Ophthalmology. 1983. 90:4–13.
5. Jabs DA, Hirst LW, Green WR, et al. The eye in bone marrow transplantation. II. Histopathology. Arch Ophthalmol. 1983. 101:585–590.
6. Riemens A, te Boome L, Imhof S, et al. Current insights into ocular graft-versus-host disease. Curr Opin Ophthalmol. 2010. 21:485–494.
7. Chiang KC, Ohmori N, Goto T. The search for immunosuppressive therapies to induce tolerance in organ transplantation. Endocr Metab Immune Disord Drug Targets. 2011. 11:173–180.
8. Janda JM, Abbott SL. The genus Hafnia: from soup to nuts. Clin Microbiol Rev. 2006. 19:12–18.
9. Ruiz-Moreno JM, Alió JL, de la Hoz F. Delayed-onset postoperative endophthalmitis caused by Hafnia alvei. Eur J Ophthalmol. 2001. 11:189–192.
10. Savini V, Di Bartolomeo E, Catavitello C, et al. Graft versus host disease-related Hafnia alvei colonization and probable infection. J Med Microbiol. 2008. 57(Pt 9):1167–1169.
11. Caravalho J Jr, McMillan VM, Ellis RB, Betancourt A. Endogenous endophthalmitis due to Salmonella arizonae and Hafnia alvei. South Med J. 1990. 83:325–327.
12. Barry JW, Dominguez EA, Boken DJ, Preheim LC. Hafnia alvei infection after liver transplantation. Clin Infect Dis. 1997. 24:1263–1264.
13. Conte M, Castagnola E, Venzano P, et al. Bacteremia caused by Hafnia alvei in a human immunodeficiency virus-infected child. Pediatr Infect Dis J. 1996. 15:182–183.
14. Mojtabaee A, Siadati A. Enterobacter hafnia meningitis. J Pediatr. 1978. 93:1062–1063.
15. Günthard H, Pennekamp A. Clinical significance of extraintestinal Hafnia alvei isolates from 61 patients and review of the literature. Clin Infect Dis. 1996. 22:1040–1045.
16. Kulkarni S, Powles R, Treleaven J, et al. Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants. Blood. 2000. 95:3683–3686.
17. Witherspoon RP, Storb R, Ochs HD, et al. Recovery of antibody production in human allogenic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood. 1981. 58:360–368.